Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2026)

Perspective Therapeutics (CATX) has 4 years of Non-Current Debt data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 3.54% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 3.54% YoY), and the FY2025 full-year result was $1.6 million, down 3.45% from the prior year.
• Non-Current Debt declined to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q3 2023 to a low of $1.6 million in Q1 2026.
• A 4-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Non-Current Debt.
• Peak annual rise in Non-Current Debt reached 2.92% in 2024, while the deepest fall reached 5.7% in 2024.
• Tracing CATX's Non-Current Debt over 4 years: stood at $1.7 million in 2023, then declined by 3.04% to $1.6 million in 2024, then retreated by 3.45% to $1.6 million in 2025, then slipped by 0.96% to $1.6 million in 2026.
• Business Quant data shows CATX's Non-Current Debt at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.